SRx Health Solutions reported net sales of $2.8 million for the quarter ended December 31, 2025, achieving a 38% gross margin, or $1.1 million gross profit. The company recorded an $8.6 million net loss, which included a $3.1 million non-cash loss on debt extinguishment, and reported an adjusted EBITDA loss of $1.06 million with diluted loss per share of $0.26.

The company finished the quarter with $13.1 million in cash and equivalents, up from $1.3 million, funded by $16.1 million in common stock and $8.9 million in preferred stock issuance. During and after the quarter, SRx Health deployed $8.5 million initially and $18.0 million in total into Bitcoin and Ethereum as part of its digital treasury strategy, while using $1.6 million to repay convertible debt.

SRx Health entered a definitive agreement to acquire EMJ Crypto Technologies, a Gen 2 digital-asset treasury platform utilizing quantitative models, AI and systematic risk controls led by Eric M. Jackson. The transaction is expected to close in the first half of calendar 2026 and aims to broaden the company’s multi-asset digital treasury management capabilities.